Security key
36315X101
Lakefront Biotherapeutics NV - Ordinary shares, no par value (LKFT)
CUSIP: 36315X101
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Ordinary shares, no par value
- Total 13F shares
- 10,793,402
- Total 13F value
- $595,046,185
- Share change
- +1,998,935
- Put/Call ratio
- 46%
- SEC-reported price per share
- $55.13
- Number of holders
- 81
- Value change
- +$111,349,568
- Number of buys
- 45
- Number of sells
- 36
- Shares outstanding
- 66,186,595
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
81
Top holders
10
LKFT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Lakefront Biotherapeutics NV SEC filings
Lakefront Biotherapeutics NV company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36315X101
Recent filing periods:
Ownership snapshot
Top reported holders of LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 2.4%
Showing 1-6 of 15 holder rows.
Quick read
EcoR1 Capital, LLC leads the comparable SEC ownership view at 2.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EcoR1 Capital, LLC's linked filing trail.
Comparable ownership
Top 5
EcoR1 Capital, LLC
2.4%
BVF INC/IL
1.7%
ORBIMED ADVISORS LLC
1.1%
683 Capital Management, LLC
1.1%
CITADEL ADVISORS LLC
0.76%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC |
13F
Company
|
2.4%
|
$82,006,000
1,558,749 shares
|
— | 30 Sep 2021 |
| BVF INC/IL |
13F
Company
|
1.7%
|
$58,909,000
1,119,733 shares
|
— | 30 Sep 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.1%
|
$38,061,000
723,457 shares
|
— | 30 Sep 2021 |
| 683 Capital Management, LLC |
13F
Company
|
1.1%
|
$36,902,000
701,421 shares
|
— | 30 Sep 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.76%
|
$26,316,000
500,218 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
0.59%
|
$20,506,000
389,759 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
81
Shares
10,793,402
Rows available
81
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
80
Q4 2021 holders
81
Holder diff
1
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend